St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Erin Podolak, MA
Managing Editor
Erin Podolak, MA, is Managing Editor, Scientific Communication in the Strategic Communication Education and Outreach Department at St. Jude.
Stories by Erin Podolak
Addressing treatment-related mortality: Student’s research spotlights need for supportive care
Gathering data increases understanding of treatment-related mortality in low- and middle-income countries.
Targeted protein degradation to treat cancer
St. Jude scientists are degrading proteins to treat cancer.
Targeting DNA damage repair gives radiation therapy a boost
Inhibiting DNA damage repair alongside radiation therapy can treat brain tumors.
Metastatic cancer cells thrive in harsh microenvironments
Like a journey through space, metastatic cells have to adapt to spread throughout the body.
Data-driven science helps researchers design new protein interactions
With a comprehensive approach to thinking about data, St. Jude scientists are fueling progress.
Liver toxicity and ALL: Genomics drive variability between patients
Research reveals how inherited genetic variants can contribute to liver toxicity after chemotherapy.
Genetics: The myth of the monolith: How molecular groups can improve cancer care
St. Jude scientists are fueling progress by studying the molecular groups of different cancers.
St. Jude scientists on the hunt for ‘holy grail’ cancer vulnerabilities
Scientists at St. Jude Children’s Research Hospital are deploying genomic technologies to hunt for vulnerabilities in cancer.
On the road to resistance: How bacteria can win the game of life ‘with a little help from their friends’
St. Jude scientists have learned that bacteria are more successful at developing antibiotic resistance when they swap genes through recombination.
Studies of rare craniopharyngioma reveal ways to improve long-term outcomes for patients
A St. Jude clinical trial launched more than 25 years ago has helped to transform understanding and care for children with the brain tumor craniopharyngioma.